Skip to main content
George Papakostas, MD, Psychiatry, Boston, MA, Massachusetts General Hospital

GeorgePapakostasMD

Psychiatry Boston, MA

Professor at Harvard Medical School and Associate Executive Director, Clinical Trials Network and Institute, Massachusetts General Hospital.

Dr. Papakostas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Papakostas' full profile

Already have an account?

Education & Training

  • Massachusetts General Hospital/McLean Hospital
    Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1999 - 2002
  • Steward Carney Hospital
    Steward Carney HospitalInternship, Internal Medicine, 1998 - 1999
  • New York University School of Medicine
    New York University School of MedicineClass of 1998

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2002 - 2024
  • American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Research Paper Tachyphylaxis in Major Depressive Disorder: A Review of the Current State of Research  
    Gustavo Kinrys, Andrew A Nierenberg, George I Papakostas, David Mischoulon, Maurizio Fava, Marlene P Freeman, ScienceDirect
  • Double-Blind, Placebo-Controlled, Dose-Ranging Trial of Intravenous Ketamine as Adjunctive Therapy in Treatment-Resistant Depression (TRD)  
    Sanjay J Mathew, Madhukar H Trivedi, Lee C Chang, Dan V Iosifescu, Manish K Jha, Maurizio Fava, Marlene P Freeman, Cristina Cusin, James Murrough, George I Papakostas,..., Nature

Lectures

  • Therapeutic Augmentation for Treatment-Resistant MDD 
    162nd Annual Meeting, San Francisco, California, USA
  • Therapeutic Augmentation for Treatment-Resistant MDD 
    American Psychiatric Association, 162nd Annual Meeting, San Francisco, California, USA

Press Mentions

  • 4 Serotonin Supplements to Treat Depression, Anxiety, & Insomnia Yourself
    4 Serotonin Supplements to Treat Depression, Anxiety, & Insomnia YourselfJune 5th, 2019
  • Allergan’s Phase III Botox Trial for Depression Pushed to H2 2019
    Allergan’s Phase III Botox Trial for Depression Pushed to H2 2019December 10th, 2018
  • Major Depression Ziprasidone
    Major Depression ZiprasidoneOctober 6th, 2017
  • Join now to see all

Grant Support

  • 1/2-Ziprasidone Augmentation Of Ssris For Treatment-Resistant Depression (TRD)National Institute Of Mental Health2008–2012
  • S-Adenosyl Methionine(Same)Augmentation Of Ssris In MDDNational Institute Of Mental Health2004–2008

Hospital Affiliations